Cystatin 9-like pseudogene 2 (CST9LP2)

Cystatin 9-like pseudogene 2 (CST9LP2) is classified as an unprocessed pseudogene located at chromosome 20p11.21 within the locus containing most type 2 cystatin genes and pseudogenes[3][6]. Unlike the protein-coding members of the cystatin superfamily—such as CST9 and CST5—that act as cysteine protease inhibitors with roles in hematopoietic differentiation, immunity, and inflammation, CST9LP2 does not encode a functional protein and thus does not serve any known biological or therapeutic function[6][11]. It is neither a receptor, enzyme, transporter, nor any recognized druggable target. There appears to be no evidence of biological role, disease association, drug interaction, or biomarker utility for CST9LP2. Using this entity as a therapeutic target would be inappropriate because it is non-functional. The presence of “pseudogene” in the name and its documentation in genomic databases confirm this classification, and the alternative names found (“CTES7D”) do not represent active gene products[3][6]. Key points: - CST9LP2 is a pseudogene, not a protein-coding gene or functional biomolecule[6]. - It is included in catalogues for completeness of the type 2 cystatin family but has no known biological or pathological function[3][11]. - No drugs, disease roles, or biomarkers have been reported for CST9LP2. - The target as presented is not appropriate for therapeutic exploitation or translational research.

Other names

CTES7DCST9LP2